This World Immunisation Week and beyond, MSF teams share access and innovation advancements that, if achieved in the years to ...

Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up ...

Illumina Inc (ILMN) reports robust Q1 performance with increased revenue and EPS, while raising 2026 guidance amid strong clinical market demand.

Cytogenetics is rapidly advancing with innovations that merge traditional chromosome analysis with automation, AI, and high-throughput genomic tools. These developments are improving speed, accuracy, ...

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss after bariatric surgery ...

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss ...

Prediabetes may leave a lasting molecular "footprint" on adipose (fat) tissue which appears to make maintaining weight loss ...

Kathleen Elison is the co-founder and principal scientist at Terray Therapeutics, where she leads the research and ...

Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smart ...

Researchers developed STRIPE, a targeted long-read RNA sequencing tool that identifies disease-causing variants missed by ...

Mechanistic insights on how NRG4 suppresses obesity-driven breast cancer metastasis Breast cancer remains a leading cause of ...

cDNA is produced from RNA templates via reverse transcription and is used in applications like RT-qPCR, microarrays, and RNA-seq. High-quality synthesis depends on intact RNA, removal of genomic DNA, ...